North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibodies, Antineoplastic, Hedgehog Pathway Inhibitors, and Others), By Route of Administration (Oral, Topical, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Forecast, 2021-2028

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI106348

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2017-2028
Base Year	2020
Estimated Year	2021
Forecast Period	2021-2028
Historical Period	2017-2019
Unit	Value (USD million)
Segmentation	Drug Class, Route of Administration; Distribution Channel; and Region
By Drug Class	Monoclonal Antibodies Antineoplastic Hedgehog Pathway Inhibitors Others
By Route of Administration	Oral Topical Parenteral
By Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Country	U.S. Canada